<DOC>
	<DOCNO>NCT00027404</DOCNO>
	<brief_summary>This study determine effect fluoxetine treatment adult autism functional ability behavior associate autism . Evidence suggest abnormal serotonin function autism . Fluoxetine selective inhibitor serotonin transporter .</brief_summary>
	<brief_title>Study Fluoxetine Adults With Autistic Disorder</brief_title>
	<detailed_description>Eligible patient undergo comprehensive evaluation . Informants familiar patient also provide information . Patients randomize receive treatment placebo . During 12-week treatment weekly monitoring first 4 week biweekly monitor next 8 week . The drug dosage increase week tolerate patient . Serum level fluoxetine norfluoxetine document Week 12 . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Inclusion criterion : Meets DSMIV ADI criterion autistic disorder Patients must use effective contraception Negative pregnancy test Clinical Global ImpressionSeverity Scale Autistic Disorder ( CGIAD ) score 4 Exclusion criterion : Pregnant nursing Prior concurrent history mental disorder , include schizophrenia , schizoaffective disorder , organic mental disorder , bipolar disorder Concurrent depression determine DSMIV diagnosis Serious suicidal risk Active seizure disorder within past 2 year Clinically significant unstable medical illness , include hematopoietic cardiovascular disease Any organic systemic disease Any geographical condition would preclude study compliance Prior concurrent gastrointestinal , liver , kidney disease Any concurrent condition interferes absorption , distribution , metabolism , excretion drug Prior concurrent cerebrovascular disease brain trauma Prior concurrent clinically significant unstable endocrine disorder , hypo hyperthyroidism Prior concurrent malignancy Clinically significant abnormality EKG , laboratory test , physical exam Requirement ECT psychotropic medication Inability tolerate taper psychoactive medication History hypersensitivity severe side effect associate use fluoxitine serotonin reuptake inhibitor Treatment drug know welldefined potential toxicity major organ within past 30 day Concurrent terfenadine ( Seldane ) astemizole ( Hismanal ) Prior treatment fluoxetine 40 mg/day 6 week Prior electroconvulsive therapy within past 3 month Prior investigational drug use within past 30 day Prior Monoamine oxidase inhibitor use within past 14 day Prior longacting phenothiazine within past 6 week Prior psychotropic drug within past 7 day Prior fluoxetine within past 6 week Requirement therapeutic intervention would confound study evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>Adult , Autism</keyword>
</DOC>